These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6880788)

  • 1. The LD50 test and in vitro toxicology strategies.
    Nardone RM
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():65-79. PubMed ID: 6880788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national validation study of the acute-toxic-class method--an alternative to the LD50 test.
    Schlede E; Mischke U; Roll R; Kayser D
    Arch Toxicol; 1992; 66(7):455-70. PubMed ID: 1444812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an in vitro test battery for the estimation of acute human systemic toxicity: An outline of the EDIT project. Evaluation-guided Development of New In Vitro Test Batteries.
    Clemedson C; Nordin-Andersson M; Bjerregaard HF; Clausen J; Forsby A; Gustafsson H; Hansson U; Isomaa B; Jørgensen C; Kolman A; Kotova N; Krause G; Kristen U; Kurppa K; Romert L; Scheers E
    Altern Lab Anim; 2002; 30(3):313-21. PubMed ID: 12106010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on the LD50 and acute eye and skin irritation tests. The Animals in Research Committee of the Society of Toxicology and approved by the SOT Council.
    Fundam Appl Toxicol; 1989 Nov; 13(4):621-3. PubMed ID: 2620785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of the QSAR and in vitro approaches for developing non-animal methods to supersede the in vivo LD50 test.
    Phillips JC; Gibson WB; Yam J; Alden CL; Hard GC
    Food Chem Toxicol; 1990 May; 28(5):375-94. PubMed ID: 2199353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative approaches in median lethality (LD50) and acute toxicity testing.
    DePass LR
    Toxicol Lett; 1989 Dec; 49(2-3):159-70. PubMed ID: 2690401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LD50 - its value for the pharmaceutical industry in safety evaluation of drugs.
    Malmfors T; Teiling A
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():229-46. PubMed ID: 6136150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals.
    Shrivastava R; Delomenie C; Chevalier A; John G; Ekwall B; Walum E; Massingham R
    Cell Biol Toxicol; 1992; 8(2):157-70. PubMed ID: 1422925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical evaluation of the fixed-dose procedure.
    Whitehead A; Curnow RN
    Food Chem Toxicol; 1992 Apr; 30(4):313-24. PubMed ID: 1628867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives to animals in toxicity testing.
    Goldberg AM; Frazier JM
    Sci Am; 1989 Aug; 261(2):24-30. PubMed ID: 2667132
    [No Abstract]   [Full Text] [Related]  

  • 11. The LD50 test.
    Paget E
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():6-19. PubMed ID: 6880787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The international validation of a fixed-dose procedure as an alternative to the classical LD50 test.
    van den Heuvel MJ; Clark DG; Fielder RJ; Koundakjian PP; Oliver GJ; Pelling D; Tomlinson NJ; Walker AP
    Food Chem Toxicol; 1990 Jul; 28(7):469-82. PubMed ID: 2210519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shortcomings of LD50-values and acute toxicity testing in animals.
    Rowan A
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():52-64. PubMed ID: 6880786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytotoxicity of 50 chemicals from the MEIC study determined by growth inhibition of ascites sarcoma BP8 cells: a comparison with acute toxicity data in man and rodents.
    Romert L; Jansson T; Jenssen D
    Toxicol Lett; 1994 Mar; 71(1):39-46. PubMed ID: 8140587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Bayesian methodology in the development and validation of a tiered assessment approach towards prediction of rat acute oral toxicity.
    Firman JW; Cronin MTD; Rowe PH; Semenova E; Doe JE
    Arch Toxicol; 2022 Mar; 96(3):817-830. PubMed ID: 35034154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The LD50 in comparison with acute toxicity. A critical evaluation of the present method].
    Bass R; Günzel P; Henschler D; König J; Lorke D; Neubert D; Schütz E; Schuppan D; Zbinden G
    Arzneimittelforschung; 1983; 33(1):81-3. PubMed ID: 6681973
    [No Abstract]   [Full Text] [Related]  

  • 17. Approximate lethal dose versus median lethal dose in acute toxicity testing of pharmaceuticals. A retrospective study.
    Vit PJ
    Arch Toxicol; 1989; 63(4):343-4. PubMed ID: 2764724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Report on the ICCVAM workshop on in vitro methods for assessing acute systemic toxicity].
    Genschow E; Liebsch M; Halle W; Spielmann H
    ALTEX; 2001; 18(2):115-6. PubMed ID: 11378685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between cytotoxicity in vitro and LD50-values.
    Ekwall B
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():80-99. PubMed ID: 6880789
    [No Abstract]   [Full Text] [Related]  

  • 20. Methodological aspects of acute toxicity testing particularly LD50 determinations present use in development of new drugs.
    Fowler JS; Rutty DA
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():20-30. PubMed ID: 6880781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.